Financials Biolog Device Co., Ltd.

Equities

A208710

KR7208710004

Electronic Equipment & Parts

End-of-day quote Korea S.E. 06:00:00 2024-05-23 pm EDT 5-day change 1st Jan Change
687 KRW -4.18% Intraday chart for Biolog Device Co., Ltd. -2.41% -21.13%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 50,204 53,373 46,917 129,266 41,832 54,525
Enterprise Value (EV) 1 63,337 64,994 82,669 150,204 55,273 59,519
P/E ratio 9.46 x 9.15 x -2.78 x -16.5 x 160 x -3.46 x
Yield - - - - - -
Capitalization / Revenue 0.62 x 0.59 x 0.51 x 1.48 x 0.39 x 0.44 x
EV / Revenue 0.78 x 0.72 x 0.9 x 1.72 x 0.52 x 0.48 x
EV / EBITDA 4.38 x 4.41 x 17.8 x -79.8 x 6.5 x 18.4 x
EV / FCF -7.79 x 5.6 x -4.39 x -2,544 x -16.7 x 9.85 x
FCF Yield -12.8% 17.9% -22.8% -0.04% -5.98% 10.2%
Price to Book 1.09 x 0.95 x 1.25 x 2.61 x 0.82 x 0.9 x
Nbr of stocks (in thousands) 27,359 28,695 28,695 41,431 42,254 62,600
Reference price 2 1,835 1,860 1,635 3,120 990.0 871.0
Announcement Date 3/19/19 3/18/20 3/22/21 3/22/22 3/20/23 3/18/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 81,464 90,419 91,793 87,280 106,488 123,469
EBITDA 1 14,467 14,735 4,633 -1,883 8,510 3,233
EBIT 1 7,987 6,997 -4,318 -9,782 557.8 -5,062
Operating Margin 9.8% 7.74% -4.7% -11.21% 0.52% -4.1%
Earnings before Tax (EBT) 1 7,015 7,028 -16,522 -9,167 6,124 -7,833
Net income 1 5,890 6,146 -16,895 -7,214 257.4 -11,810
Net margin 7.23% 6.8% -18.41% -8.27% 0.24% -9.57%
EPS 2 194.0 203.2 -589.0 -189.2 6.171 -252.0
Free Cash Flow 1 -8,126 11,609 -18,845 -59.05 -3,305 6,045
FCF margin -9.97% 12.84% -20.53% -0.07% -3.1% 4.9%
FCF Conversion (EBITDA) - 78.78% - - - 187%
FCF Conversion (Net income) - 188.89% - - - -
Dividend per Share - - - - - -
Announcement Date 3/19/19 3/18/20 3/22/21 3/22/22 3/20/23 3/18/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 13,133 11,621 35,752 20,938 13,441 4,994
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.9078 x 0.7887 x 7.717 x -11.12 x 1.58 x 1.545 x
Free Cash Flow 1 -8,126 11,609 -18,845 -59.1 -3,305 6,045
ROE (net income / shareholders' equity) 13.2% 12% -36% -18.1% 6.07% -14.7%
ROA (Net income/ Total Assets) 7.11% 5.29% -2.84% -5.97% 0.37% -3.26%
Assets 1 82,868 116,264 594,887 120,885 70,074 362,489
Book Value Per Share 2 1,687 1,956 1,310 1,195 1,212 972.0
Cash Flow per Share 2 176.0 195.0 146.0 263.0 69.00 142.0
Capex 1 4,998 10,497 26,193 2,562 1,739 2,688
Capex / Sales 6.13% 11.61% 28.53% 2.94% 1.63% 2.18%
Announcement Date 3/19/19 3/18/20 3/22/21 3/22/22 3/20/23 3/18/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A208710 Stock
  4. Financials Biolog Device Co., Ltd.